Keywords: hooks, up, ergo, bromocriptine, science, licensed, worldwide
J&J Hooks Up With Ergo For Bromocriptine
Article | 25 February 1998
Ergo Science has licensed worldwide rights to its oral dopamine agonistfor non-insulin-dependent diabetes, Ergoset (bromocriptine mesylate), to Johnson & Johnson.
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
